In their study, human-derived monocytes were treated with either PMA, pharmacologic G6PD inhibitor 6-AN, G6PD-silencing siRNA, siRNA + hyperglycemia, or hyperglycemia alone and then inspected for changes in monocyte polarization without an immunogenic stimulus
MacIntyre EA, Brauer M, Meln E, Bauer CP, Bauer M, Berdel D, et al
The legal and ethical considerations surrounding research peptide use outside of formal research settings create additional complexities for potential users and healthcare providers
Frequently Asked Questions What is the best way to take BPC-157
OPTIONS Study Phase 2b results announcement (AOD-9604 development terminated)
Lightweight Formula: Absorbs without puffiness or greasiness common with heavier eye creams